Objective assessment in Parkinson's disease: optoelectronic movement and force analysis in clinical routine and research.
Ingvarsson
P E
PE
Department of Neurology, Sahlgren University Hospital, Göteborg, Sweden.
Johnels
B
B
Steg
G
G
Olsson
T
T
D000375:Aging / Q000502:physiology; D000978:Antiparkinson Agents / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000627:therapeutic use; D004581:Electronics; D006225:Hand / Q000503:physiopathology; D018737:Hand Strength / Q000502:physiology; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008722:Methods; D009068:Movement / Q000502:physiology*; D055095:Optics and Photonics; D010300:Parkinson Disease / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology*; D011187:Posture / Q000502:physiology; D012016:Reference Values; D014202:Tremor / Q000209:etiology / Q000503:physiopathology
D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D007980:Levodopa